Publications by authors named "K Neben"

Claim this Profile
M
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries.
Anja Seckinger, Hans Salwender, Hans Martin, Christof Scheid, Thomas Hielscher, Kai Neben

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study.
Wolfgang M Brueckl, Martin Reck, Harald Schäfer, Kai Neben, Frank Griesinger

J Geriatr Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.
Marc-Andrea Baertsch, Elias K Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Kai Neben

Blood Cancer J· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma.
Maximilian Merz, Thomas Hielscher, Elias Karl Mai, Anja Seckinger, Dirk Hose, Kai Neben

Blood Cancer J· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma.
Elias K Mai, Thomas Hielscher, Uta Bertsch, Jana Schlenzka, Hans J Salwender, Kai Neben

Leukemia· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis